SLC6A3 and Parkinson disease: Dopaminergic dysfunction appears to play a minor role, as indicated by the poor correlation between fatigue severity, levodopa equivalent daily dosage (LEDD), and dopamine transporter (DAT) availability in L‐dopa‐naïve PD patients.1, 15